NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy Integration

NCT06762379

RecruitingN/A

Sponsor: European Institute of Oncology

Conditions: Metastatic Prostate Cancer (mPC)

Countries: Italy

Implementation of a new algorithm for HRR gene mutation testing in patients with mPC through liquid biopsy integration

Eligibility overview

Sex: MALE

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients with metastatic prostate cancer whose tumor tissue is unavailable or inadequate for molecular testing. • Written informed consent must be signed and dated by the patient and the investigator prior to inclusion.

Exclusion Criteria:

* Unable to provide written informed consent

Locations (1)

Milan, Italy, Italy